Natixis Neogenomics Inc Transaction History
Natixis
- $18.1 Billion
- Q1 2025
A detailed history of Natixis transactions in Neogenomics Inc stock. As of the latest transaction made, Natixis holds 150 shares of NEO stock, worth $912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$912
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NEO
# of Institutions
289Shares Held
129MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$40.8 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$36.7 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$34.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...